Down Syndrome Candidate Region 1-like 1 (DSCR1-L1) Mimics the Inhibitory Effects of DSCR1 on Calcineurin Signaling in Endothelial Cells and Inhibits Angiogenesis

Journal of Surgical Research

Volumn 142, Issue 1, 2007, Pages 129-136

  Gollogly, Lila K ^a   Ryeom, Sandra W ^b   Yoon, Sam S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

angiogenesis; calcineurin; Down syndrome candidate region 1 (DSCR1), Down syndrome candidate region 1 like 1 (DSCR1 L1)

Indexed keywords

ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR; CALCINEURIN; CALCINEURIN INHIBITOR; LENTIVIRUS VECTOR; LIOTHYRONINE; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR NFAT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DOWN SYNDROME; DSCR1 L1 GENE; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANGIOPOIETIN-1; CALCINEURIN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; TRIIODOTHYRONINE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547946180     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.10.011     Document Type: Article

References (23)

1. Klee C.B., Ren H., and Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273 (1998) 13367
2. Crabtree G.R. Generic signals and specific outcomes: Signaling through Ca2+, calcineurin, and NF-AT. Cell 96 (1999) 611
3. Zhu J., and McKeon F. Nucleocytoplasmic shuttling and the control of NF-AT signaling. Cell Mol Life Sci 57 (2000) 411
4. Liu J., Farmer Jr. J.D., Lane W.S., et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807
5. Fuentes J.J., Genesca L., Kingsbury T.J., et al. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9 (2000) 1681
6. Gorlach J., Fox D.S., Cutler N.S., et al. Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans. EMBO J 19 (2000) 3618
7. Rothermel B., Vega R.B., Yang J., et al. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275 (2000) 8719
8. Ryeom S., Greenwald R.J., Sharpe A.H., et al. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat Immunol 4 (2003) 874
9. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20 (2002) 4368
10. Faehling M., Kroll J., Fohr K.J., et al. Essential role of calcium in vascular endothelial growth factor A-induced signaling: Mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J 16 (2002) 1805
11. Armesilla A.L., Lorenzo E., Gomez D.A., et al. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression. Mol Cell Biol 19 (1999) 2032
12. Hernandez G.L., Volpert O.V., Iniguez M.A., et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193 (2001) 607
13. Johnson E.N., Lee Y.M., Sander T.L., et al. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem 278 (2003) 1686
14. Yao Y.G., and Duh E.J. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: A mechanism for feedback regulation of angiogenesis?. Biochem Biophys Res Commun 321 (2004) 648
15. Iizuka M., Abe M., Shiiba K., et al. Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis. J Vasc Res 41 (2004) 334
16. Hesser B.A., Liang X.H., Camenisch G., et al. Down syndrome critical region protein1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104 (2004) 109
17. Minami T., Horiuchi K., Miura M., et al. Vascular endothelial growth factor- and thrombin-induced termination factor, down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279 (2004) 50537
18. Miyazaki T., Kanou Y., Murata Y., et al. Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem 271 (1996) 14567
19. Cao X., Kambe F., Miyazaki T., et al. Novel human ZAKI-4 isoforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors. Biochem J 367 (2002) 459
20. Yang J., Rothermel B., Vega R.B., et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87 (2000) E61
21. Yoon S.S., Eto H., Lin C.M., et al. Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 59 (1999) 6251
22. Abe M., and Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 4 (2001) 289
23. Dietrich J.B., Kuchler-Bopp S., Boutillier S., et al. Expression of thyroid hormone receptors alpha and beta-1 messenger RNAs in human endothelial cells. The T3 hormone stimulates the synthesis of the messenger RNA of the intercellular adhesion molecule-1. Cell Mol Biol (Noisy-le-grand) 43 (1997) 1205